April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Sildenafil Reduces Retinal Sensitivity and Vision in Dogs Heterozygous for a PDE6A Mutation
Author Affiliations & Notes
  • K. E. Pierce, Jr.
    Small Animal Clinical Sci, Michigan State University, East Lansing, Michigan
  • J. T. Bartoe
    Small Animal Clinical Sci, Michigan State University, East Lansing, Michigan
  • J. Hauptman
    Small Animal Clinical Sci, Michigan State University, East Lansing, Michigan
  • C. Zelinka
    Neuroscience, The Ohio State University, Columbus, Ohio
  • A. J. Fischer
    Neuroscience, The Ohio State University, Columbus, Ohio
  • S. M. Petersen-Jones
    Small Animal Clinical Sci, Michigan State University, East Lansing, Michigan
  • Footnotes
    Commercial Relationships  K.E. Pierce, Jr., None; J.T. Bartoe, None; J. Hauptman, None; C. Zelinka, None; A.J. Fischer, None; S.M. Petersen-Jones, None.
  • Footnotes
    Support  Midwest Eye-Banks
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 70. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. E. Pierce, Jr., J. T. Bartoe, J. Hauptman, C. Zelinka, A. J. Fischer, S. M. Petersen-Jones; Sildenafil Reduces Retinal Sensitivity and Vision in Dogs Heterozygous for a PDE6A Mutation. Invest. Ophthalmol. Vis. Sci. 2009;50(13):70.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the effects of long-term, high dose sildenafil administration on ERG responses and vision in PDE6A+/- dogs.Materials &

Methods: : Five female PDE6A+/- dogs were assigned to two groups. Three dogs were dosed with sildenafil at 14.3 mg/kg per os once daily for four months. Two dogs received placebo. Ophthalmic examinations, fundus photography, electroretinography, and vision testing were performed monthly on all dogs during the pretreatment, treatment, and washout phases. Dark-adapted ERG intensity:response series and rod-mediated flicker responses were recorded followed by light adaptation and a light-adapted intensity:response series and cone flicker responses. The vision-testing device consisted of a junction box with four exit tunnels. The first-choice tunnel and exit time were recorded during repeated box exit attempts.

Results: : No ophthalmoscopic abnormalities were identified. ERGs responses recorded from dogs receiving sildenafil had raised dark-adapted b-wave thresholds with an "unmasking" of the scotopic threshold response. Significantly decreased dark-adapted a- and b-wave amplitudes (P<0.001 and P=0.002, respectively) and increased implicit times (P=0.016 and P<0.001, respectively) were also noted. Naka-Rushton fit Vmax was decreased and K was increased during the treatment phase (P=0.002, and P<0.001, respectively). Recovery of the waveforms was observed at washout. Incorrect initial tunnel choice was significantly different between the groups at the lowest light intensity (0.002 cd/m2) during the treatment phase (P=0.022).

Keywords: retina • electroretinography: non-clinical • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×